Abstract
Probiotics use different mechanisms such as intestinal barrier improvement, bacterial translocation and maintaining gut microbiota homeostasis to treat cancer. Probiotics’ ability to induce apoptosis against tumor cells makes them more effective to treat cancer. Moreover, probiotics stimulate immune function through an immunomodulation mechanism that induces an anti-tumor effect. There are different strains of probiotics, but the most important ones are lactic acid bacteria (LAB) having antagonistic and anti-mutagenic activities. Live and dead probiotics have anti-inflammatory, anti-proliferative, anti-oxidant and anti-metastatic properties which are useful to fight against different diseases, especially cancer. The main focus of this article is to review the anti-cancerous properties of probiotics and their role in the reduction of different types of cancer. However, further investigations are in progress to improve the efficiency of probiotics in cancer treatment.
Similar content being viewed by others
Data Availability
Nearly all of the data collected during this study are incorporated in this article. However data in raw form are available from the corresponding author upon request.
Abbreviations
- ALL:
-
Acute lymphocytic leukemia
- AML:
-
Acute myeloid leukemia
- BCG:
-
Bacillus galmette-guerin
- CFU:
-
Colony forming unit
- CRC:
-
Colorectal cancer
- CTL:
-
Cytotoxic T lymphocytes
- DCs:
-
Dendritic cells
- EMT:
-
Epithelial–mesenchymal transition
- EN:
-
Enteral nutrition
- GC:
-
Gastric cancer
- GIT:
-
Gastrointestinal tract
- IL-10:
-
Interleukin-10
- LAB:
-
Lactic acid bacteria
- LGG:
-
Lactobacillus rhamnosus GG
- MMP-9:
-
Matrix Metalloproteinase-9
- NK cells:
-
Natural killer cells
- TRAIL:
-
Tumor necrosis factor apoptosis-inducing ligand
- UCC:
-
Urothelial cell carcinoma
- UGIC:
-
Upper gastrointestinal cancer
- UVC:
-
Ultraviolet C
- VEGF:
-
Vascular endothelial growth factor
- WHO:
-
World Health Organization
- WT1:
-
Wilms’ tumor 1
- XCL1:
-
Chemokine C motif ligand 1
References
Ferlay J, Ervik M, Lam F et al (2020) Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon
Tripathy A, Dash J, Kancharla S et al (2021) Probiotics: a promising candidate for management of colorectal cancer. Cancers 13:3178
Mutebi M, Dehar N, Nogueira LM, Shi K, Yabroff KR, Gyawali B (2022) Cancer groundshot: building a robust cancer control platform in addition to launching the cancer moonshot. Am Soc Clin Oncol Educ Book 42:1–16
Campbell BB, Light N, Fabrizio D et al (2017) Comprehensive analysis of hypermutation in human cancer. Cell 171:1042–1056
Bedada TL, Feto TK, Awoke KS, Garedew AD, Yifat FT, Birri DJ (2020) Probiotics for cancer alternative prevention and treatment. Biomed Pharmacother 129:110409
Biswas P, Pal S, Das M, Dam S (2022) Microbe-induced oxidative stress in cancer development and efficacy of probiotics as therapeutics in preventing its onset and progression. Handbook of oxidative stress in cancer: therapeutic aspects. Springer, Singapore. https://doi.org/10.1007/978-981-16-1247-3_159-1
Hassan Z (2019) Anti-cancer and biotherapeutic potentials of probiotic bacteria. J Cancer Sci Ther 11:9–13
Daniluk U (2012) Probiotics, the new approach for cancer prevention and/or potentialization of anti-cancer treatment. J Clin Exp Oncol 1:2
Dasari S, Kathera C, Janardhan A, Kumar AP, Viswanath B (2017) Surfacing role of probiotics in cancer prophylaxis and therapy: a systematic review. Clin Nutr 36:1465–1472
Nazir Y, Hussain SA, Abdul Hamid A, Song Y (2018) Probiotics and their potential preventive and therapeutic role for cancer, high serum cholesterol, and allergic and HIV diseases. BioMed Res Int 2018:3428437
Heydari A, Parvini F, Fard NA (2022) Functional foods and antioxidant effects: emphasizing the role of probiotics; in functional food. IntechOpen, London
Chandel D, Sharma M, Chawla V, Sachdeva N, Shukla G (2019) Isolation, characterization and identification of antigenotoxic and anticancerous indigenous probiotics and their prophylactic potential in experimental colon carcinogenesis. Sci Rep 9:1–12
Khan AA, Nema V, Khan Z (2021) Current status of probiotics for prevention and management of gastrointestinal cancers. Expert Opin Biol Ther 21:413–422
Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA (2019) Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol 16:605–616
Sankarapandian V, Venmathi Maran BA, Rajendran RL et al (2022) An update on the effectiveness of probiotics in the prevention and treatment of cancer. Life 12:59
Thilakarathna WPW, Rupasinghe HV, Ridgway ND (2021) Mechanisms by which probiotic bacteria attenuate the risk of hepatocellular carcinoma. Int J Mol Sci 22:2606
Uccello M, Malaguarnera G, Basile F et al (2012) Potential role of probiotics on colorectal cancer prevention. BMC Surg 12:1–8
Lamichhane P, Maiolini M, Alnafoosi O et al (2020) Colorectal cancer and probiotics: are bugs really drugs? Cancers 12:1162
Motevaseli E, Dianatpour A, Ghafouri-Fard S (2017) The role of probiotics in cancer treatment: emphasis on their in vivo and in vitro anti-metastatic effects. Int J Mol Cell Med 6:66
Kapoor B, Singh A, Gulati M et al (2022) Orchestration of obesolytic activity of microbiome: metabiotics at centre stage. Curr Drug Metab 23:90–98
Prazdnova EV, Mazanko MS, Chistyakov VA et al (2022) Antimutagenic activity as a criterion of potential probiotic properties. Probiot Antimicrob Proteins. https://doi.org/10.1007/s12602-021-09870-9
Salehi B, Dimitrijević M, Aleksić A et al (2021) Human microbiome and homeostasis: insights into the key role of prebiotics, probiotics, and symbiotics. Crit Rev Food Sci Nutr 61:1415–1428
Chang C-J, Lin T-L, Tsai Y-L et al (2019) Next generation probiotics in disease amelioration. J food drug Anal 27:615–622
O’Toole PW, Marchesi JR, Hill C (2017) Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol 2:1–6
Saber A, Alipour B, Faghfoori Z, Yari Khosroushahi A (2017) Cellular and molecular effects of yeast probiotics on cancer. Crit Rev Microbiol 43:96–115
Kuczkowska K, Øverland L, Rocha SD, Eijsink VG, Mathiesen G (2019) Comparison of eight Lactobacillus species for delivery of surface-displayed mycobacterial antigen. Vaccine 37:6371–6379
Batista VL, Da Silva TF, de Jesus LCL et al (2020) Probiotics, prebiotics, synbiotics, and paraprobiotics as a therapeutic alternative for intestinal mucositis. Front Microbiol 11:544490
Şener D, Bulut HN, Güneş Bayir A (2021) Probiotics and relationship between probiotics and cancer types. Bezmialem Sci 9:490–497
Tripathi MK, Giri SK (2014) Probiotic functional foods: survival of probiotics during processing and storage. J Funct Foods 9:225–241
Shang X, E F-F, Guo K-L et al (2022) Effectiveness and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 randomized controlled trials. Nutrients 14:2482
Georgieva M, Georgiev K, Hvarchanova N (2022) Probiotics: past, present, and future challenges. Probiotics in the prevention and management. Elsevier, Amsterdam, pp 431–448
Syiemlieh I, Morya S (2022) Dairy and non-dairy based probiotics: a review. Pharma Innov J 11:2956–2964
Plaza-Diaz J, Ruiz-Ojeda F, Gil-Campos M, Gil A (2019) Mechanisms of action of probiotics. Adv Nutr 10:S49–S66
Smith H (2022) Key facts about probiotics and antibiotics. S Afr Pharm Assist 22:20–22
Kerry RG, Patra JK, Gouda S, Park Y, Shin H-S, Das G (2018) Benefaction of probiotics for human health: a review. J food drug Anal 26:927–939
Yadav M, Mandeep, Shukla P (2020) Probiotics of diverse origin and their therapeutic applications: a review. J Am Coll Nutr 39:469–479
Hukins R, Krumbeck J, Bindels L et al (2016) Prebiotics: why definition matter. Curr Opin Biotechnol 37:1–7
Yadav MK, Kumari I, Singh B, Sharma KK, Tiwari SK (2022) Probiotics, prebiotics and synbiotics: safe options for next-generation therapeutics. Appl Microbiol Biotechnol 106(2):505–521
Chan MZA, Liu S-Q (2022) Fortifying foods with synbiotic and postbiotic preparations of the probiotic yeast, Saccharomyces boulardii. Curr Opin Food Sci 43:216–224
Pandey K, Naik S, Vakil B (2015) Probiotics, prebiotics and synbiotics-a review. J Food Sci Technol 52:7577–7587
Agah S, Alizadeh AM, Mosavi M et al (2019) More protection of Lactobacillus acidophilus than Bifidobacterium bifidum probiotics on azoxymethane-induced mouse colon cancer. Probiot Antimicrob Proteins 11:857–864
Sharma A (2019) Importance of probiotics in cancer prevention and treatment. Recent developments in applied microbiology and biochemistry. Elsevier, Amsterdam, pp 33–45
Górska A, Przystupski D, Niemczura MJ, Kulbacka J (2019) Probiotic bacteria: a promising tool in cancer prevention and therapy. Curr Microbiol 76:939–949
Steidler L, Hans W, Schotte L et al (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352–1355
Del Carmen S, de LeBlanc AdM, Levit R et al (2017) Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model. Int Immunopharmacol 42:122–129
Wang Z, Yu Q, Gao J, Yang Q (2012) Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1. Clin Vaccine Immunol 19:174–179
Li Y, Li X, Liu H, Zhuang S, Yang J, Zhang F (2014) Intranasal immunization with recombinant Lactococci carrying human papillomavirus E7 protein and mouse interleukin–12 DNA induces E7–specific antitumor effects in C57BL/6 mice. Oncol Lett 7:576–582
Kitagawa K, Oda T, Saito H et al (2017) Development of oral cancer vaccine using recombinant Bifidobacterium displaying Wilms’ tumor 1 protein. Cancer Immunol Immunother 66:787–798
Sasaki T, Fujimori M, Hamaji Y et al (2006) Genetically engineered Bifidobacterium longum for tumor-targeting enzyme‐prodrug therapy of autochthonous mammary tumors in rats. Cancer Sci 97:649–657
Wei C, Xun A, Wei X et al (2016) Bifidobacteria expressing tumstatin protein for antitumor therapy in tumor-bearing mice. Technol Cancer Res Treat 15:498–508
Wang C, Ma Y, Hu Q et al (2016) Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors. BMC Cancer 16:1–15
Śliżewska K, Markowiak-Kopeć P, Śliżewska W (2020) The role of probiotics in cancer prevention. Cancers 13:20
Prabhurajeshwar C, Chandrakanth K (2019) Evaluation of antimicrobial properties and their substances against pathogenic bacteria in-vitro by probiotic Lactobacilli strains isolated from commercial yoghurt. Clin Nutr Experimental 23:97–115
Drago L (2019) Probiotics and colon cancer. Microorganisms 7:66
Yu A-Q, Li L (2016) The potential role of probiotics in cancer prevention and treatment. Nutr Cancer 68:535–544
Zhang L, Turner B, Ribbeck K, Ten Hagen KG (2017) Loss of the mucosal barrier alters the progenitor cell niche via Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling. J Biol Chem 292:21231–21242
Liu Y, Tran DQ, Rhoads JM (2018) Probiotics in disease prevention and treatment. J Clin Pharmacol 58:S164–S179
Yu Q, Yuan L, Deng J, Yang Q (2015) Lactobacillus protects the integrity of intestinal epithelial barrier damaged by pathogenic bacteria. Front Cell Infect Microbiol 5:26
Badgeley A, Anwar H, Modi K, Murphy P, Lakshmikuttyamma A (2021) Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives. Biochimica et Biophysica Acta (BBA) 1875:188494
Demers-Mathieu V, DaPra C, Medo E (2022) Influenza vaccine associated with the gene expression of T cell surface markers in human milk. Breastfeed Med 17:218–225
Bajaj BK, Claes IJ, Lebeer S (2021) Funct Mech Probiot. Journal of microbiology, biotechnology and food sciences 2021:321–327
Plaza-Diaz J, Muñoz-Quezada S, Gomez-Llorente C, Gil A (2012) Probiotic mechanisms of action. Ann Nutr Metab 61:160–174
Takeda K, Okumura K (2007) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr 137:791S-793S
Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y (2020) Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target therapy 5:1–17
Pachmayr E, Treese C, Stein U (2017) Underlying mechanisms for distant metastasis-molecular biology. Visc Med 33:11–20
Dillekås H, Rogers MS, Straume O (2019) Are 90% of deaths from cancer caused by metastases? Cancer Med 8:5574–5576
Yang J, Antin P, Berx G et al (2020) Guidelines and definitions for research on epithelial–mesenchymal transition. Nat Rev Mol Cell Biol 21:341–352
Hapach LA, Mosier JA, Wang W, Reinhart-King CA (2019) Engineered models to parse apart the metastatic cascade. NPJ Precis Oncol 3:1–8
Yue Y-C, Yang B-Y, Lu J et al (2020) Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway. Microb Cell Fact 19:1–12
Li X, Wang H, Du X et al (2017) Lactobacilli inhibit cervical cancer cell migration in vitro and reduce tumor burden in vivo through upregulation of E-cadherin. Oncol Rep 38:1561–1568
Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V et al (2016) Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLoS ONE 11:e0147960
Jacouton E, Chain F, Sokol H, Langella P, Bermudez-Humaran LG (2017) Probiotic strain Lactobacillus casei BL23 prevents colitis-associated colorectal cancer. Front Immunol 8:1553
Ghanavati R, Asadollahi P, Shapourabadi MB, Razavi S, Talebi M, Rohani M (2020) Inhibitory effects of Lactobacilli cocktail on HT-29 colon carcinoma cells growth and modulation of the Notch and Wnt/β-catenin signaling pathways. Microb Pathog 139:103829
Kumar RS, Kanmani P, Yuvaraj N et al (2012) Lactobacillus plantarum AS1 isolated from south Indian fermented food Kallappam suppress 1, 2-dimethyl hydrazine (DMH)-induced colorectal cancer in male Wistar rats. Appl Biochem Biotechnol 166:620–631
Maroof H, Hassan ZM, Mobarez AM, Mohamadabadi MA (2012) Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol 32:1353–1359
Han KJ, Lee N-K, Park H, Paik H-D (2015) Anticancer and anti-inflammatory activity of probiotic Lactococcus lactis NK34. J Microbiol Biotechnol 25:1697–1701
Tarrah A, Castilhos Jd, Rossi RC et al (2018) In vitro probiotic potential and anti-cancer activity of newly isolated folate-producing Streptococcus thermophilus strains. Front Microbiol 9:2214
Lee HA, Kim H, Lee K-W, Park K-Y (2015) Dead nano-sized Lactobacillus plantarum inhibits azoxymethane/dextran sulfate sodium-induced colon cancer in Balb/c mice. J Med Food 18:1400–1405
Maghsood F, Johari B, Rohani M, Madanchi H, Saltanatpour Z, Kadivar M (2020) Anti-proliferative and anti-metastatic potential of high molecular weight secretory molecules from probiotic Lactobacillus reuteri cell-free supernatant against human colon cancer stem-like cells (HT29-ShE). Int J Pept Res Ther 26:2619–2631
Chung I-C, OuYang C-N, Yuan S-N et al (2019) Pretreatment with a heat-killed probiotic modulates the NLRP3 inflammasome and attenuates colitis-associated colorectal cancer in mice. Nutrients 11:516
Noroozi E, Tebianian M, Taghizadeh M, Dadar M, Mojgani N (2021) Anticarcinogenic potential of probiotic, postbiotic metabolites and paraprobiotics on human cancer cells. In: probiotic bacteria and postbiotic metabolites role in animal and human health. Springer, Cham pp 153–177
Nouri Z, Karami F, Neyazi N et al (2016) Dual anti-metastatic and anti-proliferative activity assessment of two probiotics on HeLa and HT-29 cell lines. Cell J (Yakhteh) 18:127
Lenoir M, Del Carmen S, Cortes-Perez NG et al (2016) RETRACTED ARTICLE: Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer. J Gastroenterol 51:862–873
Motevaseli E, Azam R, Akrami SM et al (2016) The effect of Lactobacillus crispatus and Lactobacillus rhamnosusculture supernatants on expression of autophagy genes and HPV E6 and E7 oncogenes in the HeLa cell line. Cell J (Yakhteh) 17:601
Kassayova M, Bobrov N, Strojný L et al (2016) Anticancer and immunomodulatory effects of Lactobacillus plantarum LS/07, inulin and melatonin in NMU-induced rat model of breast cancer. Anticancer Res 36:2719–2728
Goulet O (2015) Potential role of the intestinal microbiota in programming health and disease. Nutr Rev 73:32–40
Shin R, Itoh Y, Kataoka M et al (2016) Anti-tumor activity of heat-killed Lactobacillus plantarum BF-LP284 on Meth-A tumor cells in BALB/c mice. Int J Food Sci Nutr 67:641–649
Lee N-K, Son S-H, Jeon EB, Jung GH, Lee J-Y, Paik H-D (2015) The prophylactic effect of probiotic Bacillus polyfermenticus KU3 against cancer cells. J Funct Foods 14:513–518
Irecta-Nájera CA, del Huizar-López R, Casas-Solís M, Castro-Félix J, Santerre A (2017) Protective effect of Lactobacillus casei on DMH-induced colon carcinogenesis in mice. Probiotics and antimicrobial proteins 9:163–171
Li J, Sung CYJ, Lee N et al (2016) Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci 113:E1306–E1315
Nami Y, Haghshenas B, Haghshenas M, Abdullah N, Yari Khosroushahi A (2015) The prophylactic effect of probiotic Enterococcus lactis IW5 against different human cancer cells. Front Microbiol 6:1317
Sivan A, Corrales L, Hubert N et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy. Science 350:1084–1089
Wu Z, Wang G, Pan D et al (2016) Inflammation-related pro-apoptotic activity of exopolysaccharides isolated from Lactococcus lactis subsp. lactis. Benefic Microbes 7:761–768
Tuo Y, Jiang S, Qian F et al (2015) Antiproliferative effect of 8 different Lactobacillus strains on K562 cells. J Dairy Sci 98:106–110
Januszewicz W, Witczak K, Wieszczy P et al (2022) Prevalence and risk factors of upper gastrointestinal cancers missed during endoscopy: a nationwide registry-based study. Endoscopy 54:653–660
Javanmard A, Ashtari S, Sabet B et al (2018) Probiotics and their role in gastrointestinal cancers prevention and treatment; an overview. Gastroenterol Hepatol Bed Bench 11:284
Yang J, Yang H, Li Y (2022) The triple interactions between gut microbiota, mycobiota and host immunity. Crit Rev Food Sci Nutr 1:1–21
Sotelo S, Manterola C, Otzen T, Morales E, Castillo I (2022) Prevalence of gastric preneoplastic lesions in first-degree relatives of patients with gastric cancer: a cross-sectional study. J Gastrointest Cancer 1–7
He F-J, Wang M-J, Yang K et al (2022) Effects of preoperative oral nutritional supplements on improving postoperative early enteral feeding intolerance and short-term prognosis for gastric cancer: a prospective, single-center, single-blind, randomized controlled trial. Nutrients 14:1472
Zhu XY, Liu F (2017) Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy. J Dig Dis 18:195–202
Bajic P, Wolfe AJ, Gupta GN (2019) The urinary microbiome: implications in bladder cancer pathogenesis and therapeutics. Urology 126:10–15
Min K, Kim HT, Lee EH, Park H, Ha Y-S (2022) Bacteria for treatment: microbiome in bladder cancer. Biomedicines 10:1783
Sangar S, Cheng MW, Yu Y (2022) Probiotics for the treatment of other skin conditions (acne, psoriasis, seborrheic dermatitis, wounds, and skin cancer). Probiotics in the Prevention and Management of Human Diseases, pp 129–137
Güneş Bayir A, Sener D, Bulut HN (2021) Probiotics and relationship between probiotics and cancer types
Gunduz M, Murakami D, Gunduz I et al (2018) Recurrent bacterial translocation from gut and sepsis in Head and neck cancer patients and its prevention by probiotics. Med Hypotheses 120:124–127
Doppalapudi R, Vundavalli S, Prabhat M (2020) Effect of probiotic bacteria on oral Candida in head-and neck-radiotherapy patients: A randomized clinical trial. J Cancer Res Ther 16:470
Kumar SS (2022) Can probiotics stop oral cancer progression? Evid-Based Dent 23:22–23
Mishra S, Rath S, Mohanty N (2020) Probiotics—A complete oral healthcare package. J Integr Med 18:462–469
Carretta MD, Quiroga J, López R, Hidalgo MA, Burgos RA (2021) Participation of short-chain fatty acids and their receptors in gut inflammation and colon cancer. Front Physiol 12:662739
Sivamaruthi BS, Kesika P, Chaiyasut C (2020) The role of probiotics in colorectal cancer management. Evidence-Based Complementary and Alternative Medicine 2020
Sambrani R, Abdolalizadeh J, Kohan L, Jafari B (2021) Recent advances in the application of probiotic yeasts, particularly Saccharomyces, as an adjuvant therapy in the management of cancer with focus on colorectal cancer. Mol Biol Rep 48:951–960
Liu A, Ma T, Xu N et al (2021) Adjunctive probiotics alleviates asthmatic symptoms via modulating the gut microbiome and serum metabolome. Microbiol Spectr 9:e00859–e00821
Sehrawat N, Yadav M, Singh M, Kumar V, Sharma VR, Sharma AK (2021) Probiotics in microbiome ecological balance providing a therapeutic window against cancer
Liu Z, Li C, Huang M et al (2015) Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial. BMC Gastroenterol 15:1–14
Ambalam P, Raman M, Purama RK, Doble M (2016) Probiotics, prebiotics and colorectal cancer prevention. Best Pract Res Clin Gastroenterol 30:119–131
Hassan Z, Mustafa S, Rahim RA, Isa NM (2016) Anti-breast cancer effects of live, heat-killed and cytoplasmic fractions of Enterococcus faecalis and Staphylococcus hominis isolated from human breast milk. Vitro Cell Dev Biology-Animal 52:337–348
Ranjbar S, Seyednejad SA, Zakeri SE, Rezaeizadeh H, Rahimi R (2021) Probiotics for prophylaxis and management of breast cancer: Preclinical and clinical evidence; in Probiotic Research in Therapeutics 159–189, Springer
Onur E, Gökmen GG, Nalbantsoy A, Kışla D (2022) Investigation of the supportive therapy potential of propolis extract and Lactobacillus acidophilus LA-5 milk combination against breast cancer in mice. Cytokine 149:155743
Liakina V, Strainienė S, Stundienė I, Maksimaitytė V, Kazėnaitė E (2022) Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis. World J Hepatol 17:1277–1290
Meng C, Bai C, Brown TD, Hood LE, Tian Q (2018) Human gut microbiota and gastrointestinal cancer. Genom Proteom Bioinform 16:33–49
Li S, Han W, He Q, Zhang W, Zhang Y (2022) Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut-Liver Axis Theory. Contrast Media & Molecular Imaging 2022
So SS, Wan ML, El-Nezami H (2017) Probiotics-mediated suppression of cancer. Curr Opin Oncol 29:62–72
Hirsch FR, Scagliotti GV, Mulshine JL et al (2017) Lung cancer: current therapies and new targeted treatments. The Lancet 389:299–311
Bradbury P, Sivajohanathan D, Chan A, Kulkarni S, Ung Y, Ellis PM (2017) Postoperative adjuvant systemic therapy in completely resected non–small-cell lung cancer: a systematic review. Clin Lung Cancer 18:259–273 e258
Tian Y, Li M, Song W, Jiang R, Li YQ (2019) Effects of probiotics on chemotherapy in patients with lung cancer. Oncol Lett 17:2836–2848
Sharma A, Viswanath B, Park Y-S (2018) Role of probiotics in the management of lung cancer and related diseases: An update. J Funct Foods 40:625–633
Cascardi E, Cazzato G, Daniele A et al (2022) Association between Cervical Microbiota and HPV: Could This Be the Key to Complete Cervical. Cancer Eradication? Biology 11:1114
Seyyedi Z, Parchebafi A, Kashani HH (2022) The microbiota, secondary metabolites and diseases: a putative role of probiotics in prevention and treatment of cancers
Wen Y, Jin R, Chen H (2019) Interactions between gut microbiota and acute childhood leukemia. Front Microbiol 10:1300
Kheyrandish S, Rastgar A, Hamidi M, Sajjadi SM, Sarab GA (2022) Evaluation of anti-tumor effect of the exopolysaccharide from new cold-adapted yeast, Rhodotorula mucilaginosa sp. GUMS16 on chronic myeloid leukemia K562 cell line. Int J Biol Macromol 206:21–28
Hai Y, Hong Y, Yang Y (2022) miR-1258 Enhances the Anti-Tumor Effect of Liver Cancer Natural Killer (NK) Cells by Stimulating Toll-Liker Receptor (TLR) 7/8 to Promote Natural Killer (NK)-Dendritic Cell (DC) Interaction. J Biomaterials Tissue Eng 12:1241–1246
Acknowledgements
For the current study authors are extremely obliged to the Department of Zoology, Govt. College University, Lahore, Pakistan, for provision of research facilities.
Funding
Funding was not available for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This article does not contain any studies with human participants or animals accomplished by any of the authors.
Consent to participate
Not applicable.
Informed consent
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declared no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Noor, S., Ali, S., Riaz, S. et al. Chemopreventive role of probiotics against cancer: a comprehensive mechanistic review. Mol Biol Rep 50, 799–814 (2023). https://doi.org/10.1007/s11033-022-08023-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-022-08023-7